# Prose Review — Gemini 3 Flash (Round 1)

**Role:** Prose editor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T15:31:00.597283
**Route:** Direct Google API + PDF
**Tokens:** 22719 in / 1226 out
**Response SHA256:** 330fe14b78e0b4bf

---

# Section-by-Section Review

## The Opening
**Verdict:** Slow start / Needs complete rewrite

The paper opens with a date and a bureaucratic event: "In December 2025, the European Commission published a proposal..." This is classic throat-clearing. You are burying the lead. The actual hook is hidden in your title and the third paragraph: a massive regulatory overhaul that the industry claimed would be a "catastrophe," yet resulted in... nothing.

**Shleifer-style rewrite:**
"Industry groups warned of a regulatory catastrophe. When the EU Medical Device Regulation (MDR) replaced decades-old directives in 2021, cost estimates reached €3.3 billion annually and trade groups cautioned that 'innovation is at risk.' Yet five years later, the predicted collapse in European medical device production is missing. The dog did not bark."

## Introduction
**Verdict:** Solid but improvable

The introduction follows the correct arc, but the "what we find" section is a bit too timid. You state, "the estimate is not statistically distinguishable from zero." In the Shleifer tradition, a null result should be framed as a "precisely estimated zero" that rules out the alarmist claims.

**Specific suggestions:**
- **The Contribution:** Page 4 spends a lot of time listing papers (Budish, Williams, etc.). Weave these into the narrative of *why* devices are different from pharma (Katz sensibility).
- **The Roadmap:** Page 4, last paragraph ("The remainder of the paper proceeds...") is unnecessary. Shleifer rarely uses these. If your section headers are clear, the reader doesn't need a table of contents in prose.

## Background / Institutional Context
**Verdict:** Vivid and necessary

Section 2.2 is excellent. Phrases like "collapsed from roughly 80... to approximately 20" provide the **Glaeser-style narrative energy**. The reader can *see* the bottleneck. This section effectively builds the "threat" that your results eventually debunk.

## Data
**Verdict:** Reads as inventory

Section 3 feels like a manual. You describe the `sts_inpr_a` code and bulk download facilities. Shleifer would relegate the technical codes to an appendix and focus the prose on the *economic* meaning of the data. 

**Rewrite example:**
Instead of: "We extract data for four NACE Rev. 2 sectors: C325... C21... C265..."
Try: "We track the pulse of European manufacturing through Eurostat’s industrial production indices. We compare the medical device sector (NACE C325) against three natural neighbors: pharmaceuticals, electronics, and precision instruments."

## Empirical Strategy
**Verdict:** Clear to non-specialists

The explanation of the DiD logic on page 10 is very good: "This within-country, across-sector variation allows us to control for country-level shocks—including the COVID-19 pandemic..." This is the "inevitability" Shleifer aims for. However, Equation 2 is likely unnecessary for the main text; the prose already explained the parallel trends assumption perfectly.

## Results
**Verdict:** Tells a story

You do a good job of moving past the tables. The sentence on page 16—"Our preferred estimate of 3.8 index points represents a 3.8% differential change... modest compared to the industry’s predicted disruption"—is exactly what is needed. You are telling the reader what they *learned*.

**The Katz Touch:** On page 23, you discuss the "Volume versus variety" trade-off. This is the most important part of the paper for "actual families and workers." Expand this. If a specialized surgical tool for a rare pediatric condition disappears, the "production volume" doesn't move, but the human cost is infinite. 

## Discussion / Conclusion
**Verdict:** Resonates

The final section is strong. The reframing of the MDR as "regulatory harmonization" rather than just "tightening" is a classic Shleifer move—taking a result and providing a new conceptual lens. The "Open Question" paragraph is a punchy way to end.

---

## Overall Writing Assessment

- **Current level:** Close but needs polish. The structure is academic-standard; the prose needs to be "distilled to its essence."
- **Greatest strength:** The institutional detail (Section 2) is concrete and sets the stakes effectively.
- **Greatest weakness:** The opening paragraph is too "report-like." It lacks the "inevitable" hook.
- **Shleifer test:** Yes, a smart non-economist could follow this, but they might stop reading after the first paragraph.
- **Top 5 concrete improvements:**
  1. **Kill the bureaucratic opening.** Start with the "Dog that didn't bark" metaphor or the €3.3 billion cost vs. the flat production line.
  2. **Active Voice.** Change "The MDR was adopted..." to "The EU adopted the MDR..." (Page 5). 
  3. **Data Narrative.** Remove the Eurostat dataset codes (`sts_inpr_a`) from the primary prose. They break the rhythm.
  4. **The "Katz" Mechanism.** Elevate the "Volume vs. Variety" discussion. This is the soul of the paper. Use more vivid language about what "product rationalization" means (e.g., losing niche surgical tools).
  5. **Prune the Lit Review.** Page 4 is a "shopping list." Instead of "Olson (1997) documented...", try "Stricter oversight often delays access to life-saving drugs (Olson 1997), but we find..."